Literature DB >> 11136732

Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes.

A Bonacchi1, P Romagnani, R G Romanelli, E Efsen, F Annunziato, L Lasagni, M Francalanci, M Serio, G Laffi, M Pinzani, P Gentilini, F Marra.   

Abstract

Hepatic stellate cells (HSC) and glomerular mesangial cells (MC) are tissue-specific pericytes involved in tissue repair, a process that is regulated by members of the chemokine family. In this study, we explored the signal transduction pathways activated by the chemokine receptor CXCR3 in vascular pericytes. In HSC, interaction of CXCR3 with its ligands resulted in increased chemotaxis and activation of the Ras/ERK cascade. Activation of CXCR3 also stimulated Src phosphorylation and kinase activity and increased the activity of phosphatidylinositol 3-kinase and its downstream pathway, Akt. The increase in ERK activity was inhibited by genistein and PP1, but not by wortmannin, indicating that Src activation is necessary for the activation of the Ras/ERK pathway by CXCR3. Inhibition of ERK activation resulted in a decreased chemotactic and mitogenic effect of CXCR3 ligands. In MC, which respond to CXCR3 ligands with increased DNA synthesis, CXCR3 activation resulted in a biphasic stimulation of ERK activation, a pattern similar to the one observed in HSC exposed to platelet-derived growth factor, indicating that this type of response is related to the stimulation of cell proliferation. These data characterize CXCR3 signaling in pericytes and clarify the relevance of downstream pathways in the modulation of different biologic responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11136732     DOI: 10.1074/jbc.M010303200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  81 in total

Review 1.  Chemokine receptors and neural function.

Authors:  Charlene Cho; Richard J Miller
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

2.  The chemokine CXCL9 exacerbates chemotherapy-induced acute intestinal damage through inhibition of mucosal restitution.

Authors:  Huili Lu; Hongyu Liu; Jiaxian Wang; Jiaqing Shen; Shunyan Weng; Lei Han; Tao Sun; Lan Qian; Mingyuan Wu; Shunying Zhu; Yan Yu; Wei Han; Jianwei Zhu; Anja Moldenhauer
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-15       Impact factor: 4.553

Review 3.  Functional role of chemokines in liver disease models.

Authors:  Hacer Sahin; Christian Trautwein; Hermann E Wasmuth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-26       Impact factor: 46.802

4.  Cytoskeletal rearrangement and Src and PI-3K-dependent Akt activation control GABA(B)R-mediated chemotaxis.

Authors:  Madhavi J Rane; Jon B Klein; Michelle T Barati; Janice Scherzer; Rui Wu
Journal:  Cell Signal       Date:  2015-02-26       Impact factor: 4.315

5.  Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C.

Authors:  M Diago; G Castellano; J García-Samaniego; C Pérez; I Fernández; M Romero; O L Iacono; C García-Monzón
Journal:  Gut       Date:  2005-09-08       Impact factor: 23.059

Review 6.  Chemokines in the immunopathogenesis of hepatitis C infection.

Authors:  Mathis Heydtmann; David H Adams
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

Review 7.  Molecular pathways: hepatitis C virus, CXCL10, and the inflammatory road to liver cancer.

Authors:  Jessica Brownell; Stephen J Polyak
Journal:  Clin Cancer Res       Date:  2013-01-15       Impact factor: 12.531

8.  CXCL5 overexpression is associated with late stage gastric cancer.

Authors:  Jeong Youp Park; Kyung Hwa Park; Seungmin Bang; Myoung Hwan Kim; Ji-Eun Lee; Jingu Gang; Sang Seok Koh; Si Young Song
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-04       Impact factor: 4.553

9.  Alteration of podocytes in a murine model of crescentic glomerulonephritis.

Authors:  Valérie Besse-Eschmann; Michel Le Hir; Nicole Endlich; Karlhans Endlich
Journal:  Histochem Cell Biol       Date:  2004-08       Impact factor: 4.304

10.  CCR1 and CCR5 promote hepatic fibrosis in mice.

Authors:  Ekihiro Seki; Samuele De Minicis; Geum-Youn Gwak; Johannes Kluwe; Sayaka Inokuchi; Christina A Bursill; Josep M Llovet; David A Brenner; Robert F Schwabe
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.